BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21515957)

  • 41. Pleomorphic xanthoastrocytoma arising from the suprasellar region: A report of two cases.
    Jiang GY; Yu JH; Zhang XY; Qi XL; Sun YS
    J Clin Neurosci; 2016 Nov; 33():228-231. PubMed ID: 27452134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
    Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
    Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moyamoya disease in a patient with brain tumor: case report.
    Dezmalj-Grbelja L; Bosnjak J; Lovrencić-Huzjan A; Ivica M; Demarin V
    Acta Clin Croat; 2010 Dec; 49(4):459-63. PubMed ID: 21830458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late sequelae of treated pleomorphic xanthoastrocytoma: malignant brain stem astrocytoma occurring 15 years after radiation therapy.
    Fuller GN; Kaba SE; Ginsberg LE; McCutcheon IE; Langford LA
    J Neurooncol; 1997 Mar; 32(1):57-61. PubMed ID: 9049863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary multicentric anaplastic pleomorphic xanthoastrocytoma with atypical features.
    Montano N; Papacci F; Cioni B; Gaudino S; Della Pepa GM; Conforti G; Di Bonaventura R; Novello M; Lauriola L; Meglio M
    J Clin Neurosci; 2013 Nov; 20(11):1605-8. PubMed ID: 23827171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pleomorphic xanthoastrocytoma: a brief review.
    Shaikh N; Brahmbhatt N; Kruser TJ; Kam KL; Appin CL; Wadhwani N; Chandler J; Kumthekar P; Lukas RV
    CNS Oncol; 2019 Nov; 8(3):CNS39. PubMed ID: 31535562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.
    Serafini NB; Serafini CB; Vinhas AS; Godinho MB
    An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
    Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pleomorphic xanthoastrocytoma--report of four cases, with MRI scan appearances and literature review.
    Davies KG; Maxwell RE; Seljeskog E; Sung JH
    Br J Neurosurg; 1994; 8(6):681-9. PubMed ID: 7718164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients.
    Yu S; He L; Zhuang X; Luo B
    Acta Radiol; 2011 Mar; 52(2):223-8. PubMed ID: 21498352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic accuracy of diffusion weighted imaging for differentiation of supratentorial pilocytic astrocytoma and pleomorphic xanthoastrocytoma.
    She D; Liu J; Zeng Z; Xing Z; Cao D
    Neuroradiology; 2018 Jul; 60(7):725-733. PubMed ID: 29797290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neurofibromatosis with occlusion of the internal carotid artery: case report].
    Kuwayama N; Takahashi S; Sonobe M; Kagawa S; Ikeda H
    No Shinkei Geka; 1985 Jul; 13(7):743-7. PubMed ID: 3930983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Moyamoya disease as a cause of ischemic cerebral stroke in young people].
    Borowik H; Pogorzelski R; Drozdowski W
    Przegl Lek; 2006; 63(8):691-4. PubMed ID: 17441385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Moyamoya disease associated with persistent primitive trigeminal artery--a case report and review of literature].
    Kinjo T; Mukawa J; Takara E; Nakasone S; Kuda H; Ishikawa Y
    No Shinkei Geka; 1988 Aug; 16(9):1107-12. PubMed ID: 3060754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H Mutation.
    Tourne M; Tauziède-Espariat A; Dezamis E; Saffroy R; Dhermain F; Chrétien F; Varlet P
    World Neurosurg; 2018 Aug; 116():316-321. PubMed ID: 29859360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Emergency Bypass Surgery for Progressive Cerebral Infarction Following Hemorrhagic Onset of Moyamoya Disease:A Case Report].
    Hatakeyama J; Yanagisawa T; Kudo E; Togashi S; Shimizu H
    No Shinkei Geka; 2016 Oct; 44(10):843-849. PubMed ID: 27729604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CT and MRI of pleomorphic xanthoastrocytoma: unusual biologic behavior.
    Petropoulou K; Whiteman ML; Altman NR; Bruce J; Morrison G
    J Comput Assist Tomogr; 1995; 19(6):860-5. PubMed ID: 8537516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-anaplastic pleomorphic xanthoastrocytoma with neuroradiological evidences of leptomeningeal dissemination.
    Passone E; Pizzolitto S; D'Agostini S; Skrap M; Gardiman MP; Nocerino A; Scarzello G; Perilongo G
    Childs Nerv Syst; 2006 Jun; 22(6):614-8. PubMed ID: 16369851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis.
    Barrall JL; Summers CG
    Surv Ophthalmol; 1996; 40(6):500-4. PubMed ID: 8724642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benign brain stem lesions in pediatric patients with neurofibromatosis: case reports.
    Raffel C; McComb JG; Bodner S; Gilles FE
    Neurosurgery; 1989 Dec; 25(6):959-64. PubMed ID: 2513523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.